Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,984 | -38,946 | -25,490 | -28,208 | -19,448 |
| Depreciation Amortization | 5,638 | 7,934 | 2,986 | 2,635 | 2,095 |
| Accounts receivable | 1 | 107 | -161 | 537 | -498 |
| Accounts payable and accrued liabilities | 1,171 | 134 | -1 | -28 | -196 |
| Other Working Capital | 611 | 1,128 | -1,435 | -255 | -1,899 |
| Other Operating Activity | 2,913 | 4,529 | 5,507 | 9,452 | 8,195 |
| Operating Cash Flow | $-39,650 | $-25,113 | $-18,593 | $-15,868 | $-11,751 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 176 | N/A | N/A | N/A |
| PPE Investments | -10,675 | -6,590 | -10,169 | -2,677 | -1,875 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,569 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 2 |
| Purchase Sale Intangibles | -869 | -197 | -24 | -57 | -4,260 |
| Other Investing Activity | -721 | -195 | -24 | -57 | -4,261 |
| Investing Cash Flow | $-11,396 | $-6,609 | $-10,193 | $-2,733 | $-7,702 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,546 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 17,450 | 73,090 | 14,804 | 43,286 | 19,647 |
| Common Stock Repurchased | -1,039 | -9,976 | -3,978 | N/A | N/A |
| Other Financing Activity | -471 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $30,486 | $63,114 | $10,827 | $43,286 | $19,647 |
| Exchange Rate Effect | 190 | -148 | 276 | -317 | -80 |
| Beginning Cash Position | 52,813 | 21,568 | 39,252 | 14,885 | 14,771 |
| End Cash Position | 32,444 | 52,813 | 21,568 | 39,252 | 14,885 |
| Net Cash Flow | $-20,369 | $31,245 | $-17,684 | $24,368 | $114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,650 | -25,113 | -18,593 | -15,868 | -11,751 |
| Capital Expenditure | -10,675 | -6,590 | -10,169 | -2,677 | -1,875 |
| Free Cash Flow | -50,325 | -31,703 | -28,763 | -18,545 | -13,626 |